Founded in 2014 and headquartered in France, Coave Therapeutics recently received a grant investment on 16 February 2024 from The ALS Association. The company operates in the biotechnology and life sciences industries, with a vision to bring hope to patients with rare diseases through pioneering gene therapies.
Coave Therapeutics
Coave therapeutics new brand for Horama
Founded 2014
France
36 employees
Grant
Total: $79.10M
Biotechnology, Life Sciences
France
36 employees
Grant
Total: $79.10M
Biotechnology, Life Sciences
General Information
Get notified when Coave Therapeutics moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Coave Therapeutics
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
France Market
Biotechnology
About Coave Therapeutics
Taxonomy: gene therapy, ophthalmic disorders, CNS disorders, rare diseases, clinical stage company, AAV-Ligand Conjugates technology, ALIGATER platform, gene transduction, tissue distribution, unmet medical needs
Funding Rounds & Investors (7)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Grant | •••••• | 1 | •••• •••• | 16 Feb 2024 |
| Series B | •••••• | 8 |
|
21 Jul 2021 |
| Series B | •••••• | 1 |
|
18 Sep 2018 |
| Series B | •••••• | 7 |
|
08 Nov 2017 |
| Series A | •••••• | - | 15 Nov 2016 |
Coave Therapeutics Alternatives & Competitors
Coave Therapeutics vs
Coave Therapeutics vs
Pioneering gene therapies for rare neurological and liver diseases, targeting Alpha-1 Antitrypsin De...
Series A
Biotechnology, Health Care
Coave Therapeutics vs
Amarna Therapeutics
The Netherlands
Next generation gene therapy | unlocking the potential & expanding the boundaries
Grant
19 employees
Biotechnology, Pharmaceutical
FAQ About Coave Therapeutics
Coave therapeutics new brand for Horama
Coave Therapeutics was founded in 2014.
Coave Therapeutics is headquartered in France.
Coave Therapeutics operates in the following industries: Biotechnology, Life Sciences.
Coave Therapeutics has approximately 36 employees.
Coave Therapeutics has completed 7 funding rounds, raising a total of $79.10M. The latest funding stage is Grant.
Top alternatives and competitors to Coave Therapeutics include Epigenic Therapeutics, Apic Bio, Amarna Therapeutics, Ixaka, Taysha Gene Therapies. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Coave Therapeutics and Epigenic Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Don't just browse. Track.
Signal Tracker monitors Coave Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.